Your browser doesn't support javascript.
loading
Minimal residual disease and outcome characteristics in infant KMT2A-germline acute lymphoblastic leukaemia treated on the Interfant-06 protocol.
Stutterheim, J; de Lorenzo, P; van der Sluis, I M; Alten, J; Ancliffe, P; Attarbaschi, A; Aversa, L; Boer, J M; Biondi, A; Brethon, B; Diaz, P; Cazzaniga, G; Escherich, G; Ferster, A; Kotecha, R S; Lausen, B; Leung, Alex Wk; Locatelli, F; Silverman, L; Stary, J; Szczepanski, T; van der Velden, V H J; Vora, A; Zuna, J; Schrappe, M; Valsecchi, M G; Pieters, R.
Afiliação
  • Stutterheim J; Pediatric Oncology, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands. Electronic address: j.stutterheim@prinsesmaximacentrum.nl.
  • de Lorenzo P; Center of Bioinformatics, Biostatistics and Bioimaging, University of Milano-Bicocca, Monza, Italy; Pediatrics, School of Medicine and Surgery, University of Milano- Bicocca, Fondazione MBBM/San Gerardo Hospital, Monza, Italy.
  • van der Sluis IM; Pediatric Oncology, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
  • Alten J; Pediatrics, University Medical Center Schleswig-Holstein, Christian-Albrechts-University of Kiel, Germany.
  • Ancliffe P; United Kingdom Children Cancer Study Group, London, United Kingdom.
  • Attarbaschi A; St Anna Children's Hospital, Pediatric Hematology and Oncology, Austria.
  • Aversa L; GATLA, Buenos Aires, Argentina.
  • Boer JM; Pediatric Oncology, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Oncode Institute, Utrecht, the Netherlands.
  • Biondi A; Pediatrics, School of Medicine and Surgery, University of Milano- Bicocca, Fondazione MBBM/San Gerardo Hospital, Monza, Italy.
  • Brethon B; Department of Pediatric Hematology, University Robert Debre Hospital, APHP, Paris, France.
  • Diaz P; Chilean National Pediatric Oncology Group, Santiago, Chile.
  • Cazzaniga G; Tettamanti Research Center, Pediatrics, School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.
  • Escherich G; German Cooperative Study Group for Childhood Acute Lymphoblastic Leukemia, Hamburg, Germany.
  • Ferster A; European Organisation for Research and Treatment of Cancer Children Leukemia Group, Brussels, Belgium.
  • Kotecha RS; Australian and New Zealand Children's Haematology/Oncology Group, Perth Children's Hospital, Perth, Australia; Telethon Kids Cancer Centre, Telethon Kids Institute, University of Western Australia, Perth, Australia.
  • Lausen B; Rigshospitalet, University Hospital, Department of Pediatrics, Copenhagen, Denmark.
  • Leung AW; The Chinese University of Hong Kong, Shatin, Hong Kong, Special Administrative Region, People's Republic of China.
  • Locatelli F; Department of Pediatric Haematology and Oncology, IRCCS Ospedale Pediatrico Bambino Gesù, Sapienza University of Rome, Rome, Italy.
  • Silverman L; Dana-Farber Cancer Institute, Pediatric Oncology, Boston, MA, USA.
  • Stary J; Czech Working Group for Pediatric Hematology, Prague, Czech Republic.
  • Szczepanski T; Polish Pediatric Leukemia/Lymphoma Study Group, Department of Pediatric Hematology and Oncology, Medical University of Silesia, Zabrze, Katowice, Poland.
  • van der Velden VHJ; Department of Immunology, Erasmus University Medical Center, the Netherlands.
  • Vora A; United Kingdom Children Cancer Study Group, London, United Kingdom.
  • Zuna J; CLIP, Department of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic.
  • Schrappe M; Berlin-Frankfurt-Miu (¨)nster Group Germany, Kiel, Germany.
  • Valsecchi MG; Center of Bioinformatics, Biostatistics and Bioimaging, University of Milano-Bicocca, Monza, Italy.
  • Pieters R; Pediatric Oncology, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Dutch Childhood Oncology Group, Utrecht, the Netherlands.
Eur J Cancer ; 160: 72-79, 2022 01.
Article em En | MEDLINE | ID: mdl-34785111

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasia Residual / Leucemia-Linfoma Linfoblástico de Células Precursoras Tipo de estudo: Prognostic_studies Limite: Female / Humans / Infant / Male Idioma: En Revista: Eur J Cancer Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasia Residual / Leucemia-Linfoma Linfoblástico de Células Precursoras Tipo de estudo: Prognostic_studies Limite: Female / Humans / Infant / Male Idioma: En Revista: Eur J Cancer Ano de publicação: 2022 Tipo de documento: Article